X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (612) 612
Patent (79) 79
Magazine Article (42) 42
Conference Proceeding (15) 15
Dissertation (4) 4
Publication (3) 3
Book / eBook (2) 2
Book Chapter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
私营企业 (45) 45
physics (36) 36
index medicus (35) 35
chemistry (22) 22
metallurgy (22) 22
humans (21) 21
calculating (18) 18
computing (18) 18
counting (18) 18
个体私营经济 (18) 18
国有企业 (17) 17
对策 (17) 17
animals (13) 13
image data processing or generation, in general (12) 12
measuring (12) 12
testing (12) 12
human necessities (11) 11
个体工商户 (11) 11
中国 (11) 11
cancer (10) 10
社会主义市场经济 (10) 10
beer (9) 9
biochemistry (9) 9
cell biology (9) 9
investigating or analysing materials by determining theirchemical or physical properties (9) 9
mice (9) 9
microbiology (9) 9
乡镇企业 (9) 9
私营经济 (9) 9
analysis (8) 8
electricity (8) 8
enzymology (8) 8
medicine (8) 8
mutation or genetic engineering (8) 8
spirits (8) 8
vinegar (8) 8
wine (8) 8
民营经济 (8) 8
经济发展 (8) 8
basic electric elements (7) 7
chemotherapy (7) 7
compositions thereof (7) 7
culture media (7) 7
handling record carriers (7) 7
lung cancer (7) 7
microorganisms or enzymes (7) 7
performing operations (7) 7
presentation of data (7) 7
propagating, preserving or maintaining microorganisms (7) 7
recognition of data (7) 7
record carriers (7) 7
research article (7) 7
transporting (7) 7
treatment of water, waste water, sewage, or sludge (7) 7
个体经济 (7) 7
企业 (7) 7
社会主义初级阶段 (7) 7
问题 (7) 7
agriculture (6) 6
animal husbandry (6) 6
apoptosis (6) 6
expression (6) 6
fishing (6) 6
forestry (6) 6
gene expression (6) 6
hunting (6) 6
nanoparticles (6) 6
oncology (6) 6
organic chemistry (6) 6
proteins (6) 6
science (6) 6
trapping (6) 6
个体私营企业 (6) 6
中小企业 (6) 6
民营企业 (6) 6
私营部门 (6) 6
非公有制经济 (6) 6
风险分担 (6) 6
cancer therapies (5) 5
economics (5) 5
female (5) 5
health aspects (5) 5
immunology (5) 5
male (5) 5
mutation (5) 5
optics (5) 5
patients (5) 5
ppp模式 (5) 5
public health (5) 5
企业发展 (5) 5
商品经济 (5) 5
私营企业主 (5) 5
金融机构 (5) 5
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (4) 4
antioxidants (4) 4
china (4) 4
cisplatin (4) 4
cultivation of vegetables, flowers, rice, fruit, vines, hopsor seaweed (4) 4
diagnosis (4) 4
earth drilling (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Remote Sensing, ISSN 2072-4292, 11/2018, Volume 10, Issue 11, p. 1821
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0172982
When individuals in social groups communicate with one another and are under the influence of neighbors' opinions, they typically revise their own opinions to... 
DYNAMICS | NETWORKS | MODEL | MULTIDISCIPLINARY SCIENCES | Models, Theoretical | Peer Group | Algorithms | Public Opinion | Time Factors | Humans | Influence | Social groups | Public opinion | Confidence | Analysis | Neighborhood | Simulation | Basic converters | Statistical physics | Bias | Peers | Science | Evolution | Behavior | Markov analysis | Variation | Social impact | Convergence
Journal Article
Macromolecular Rapid Communications, ISSN 1022-1336, 12/2017, Volume 38, Issue 23, pp. 1700446 - n/a
The constant demand for functional nanomaterials from natural biomass polymers usually requires new “green” synthetic strategies without using any foreign... 
polyphenol nanoparticles | biomass polymer | antioxidants | green chemistry | POLYMER SCIENCE | CHEMICALS | ONE-POT | BIOMASS | POLYMERIZATION | THEOPHYLLINE | POLYDOPAMINE | ATOM | Antioxidants | Nanoparticles | Polyphenols | Green chemistry | Green tea | Green technology | Self assembly | Additives | Scavenging | Nanomaterials | Copolymerization | Biomass | Monomers | Functional materials | Fabrication | Tea | Self-assembly | Polymers | Nanotechnology | Melanin | Theophylline
Journal Article
Physical Review Letters, ISSN 0031-9007, 03/2019, Volume 122, Issue 11, p. 117401
We study two-dimensional hexagonal photonic lattices of silicon Mie resonators with a topological optical band structure in the visible spectral range. We use... 
PHYSICS, MULTIDISCIPLINARY | GAAS | Optical lattices | Superstructures | Unit cell | Band structure of solids | Cones | Domain walls | Visible spectrum | Silicon | Topology | Photonics | Optical density
Journal Article
Applied Physics Letters, ISSN 0003-6951, 07/2019, Volume 115, Issue 5
We report on surface plasmons in the visible range in hexagonal close-packed (HCP) gold nanoparticles, synthesized by metastable solidification of Au-Ge... 
Gold | Electron diffraction | Energy measurement | Lattice parameters | Solidification | Nanoparticles | Energy transmission | Face centered cubic lattice | Optical properties | Germanium | Plasmons | Nanowires | Microscopes | Spatial resolution
Journal Article
Journal of Dentistry, ISSN 0300-5712, 11/2018, Volume 78, pp. 83 - 90
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2013, Volume 35, Issue 1, pp. 54 - 65
Abstract Background Continuation maintenance treatment with pemetrexed is approved by current clinical guidelines as a category 2A recommendation after... 
Internal Medicine | Medical Education | lung | cost-effectiveness | pemetrexed | cancer | continuation maintenance treatment | 1ST-LINE CHEMOTHERAPY | PHASE-III | DOCETAXEL | GEMCITABINE | SUPPORTIVE CARE | THERAPY | PHARMACOLOGY & PHARMACY | PLUS | Drug Costs | Lung Neoplasms - drug therapy | Markov Chains | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Models, Economic | Cisplatin - administration & dosage | Glutamates - economics | Clinical Trials, Phase III as Topic | Delivery of Health Care - economics | Time Factors | China | Antineoplastic Combined Chemotherapy Protocols - economics | Carcinoma, Non-Small-Cell Lung - pathology | Quality-Adjusted Life Years | Drug Administration Schedule | Guanine - economics | Treatment Outcome | Cisplatin - economics | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Randomized Controlled Trials as Topic | Carcinoma, Non-Small-Cell Lung - economics | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cost-Benefit Analysis | Glutamates - administration & dosage | Lung Neoplasms - economics | Carcinoma, Non-Small-Cell Lung - drug therapy | Guanine - administration & dosage | Health care industry | Respiratory agents | Chemotherapy | Lung cancer, Non-small cell | Cisplatin | Cancer | Studies | Health care expenditures | Sensitivity analysis | Epidermal growth factor | Lung cancer | Histology | Cancer therapies | Estimates
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e55917
Introduction: Lung cancer, the most prevalent malignant cancer in the world, remains a serious threat to public health. Recently, a large number of studies... 
PHASE-III TRIAL | GENE-MUTATIONS | GROWTH-FACTOR RECEPTOR | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | 2ND-LINE TREATMENT | ECONOMIC OUTCOMES | OPEN-LABEL | GEFITINIB THERAPY | COMBINATION | EGFR | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Costs and Cost Analysis | Deoxycytidine - administration & dosage | Humans | Carboplatin - administration & dosage | Male | Models, Economic | Deoxycytidine - economics | Carboplatin - economics | Carcinoma, Non-Small-Cell Lung - economics | Time Factors | Antineoplastic Combined Chemotherapy Protocols - economics | Female | Quinazolines - administration & dosage | Lung Neoplasms - economics | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - economics | Far East | Deoxycytidine - analogs & derivatives | Tyrosine | Economic aspects | Cost benefit analysis | Lung cancer, Non-small cell | Chemotherapy | Erlotinib | Gene mutations | Analysis | Markov processes | Genetic aspects | Health aspects | Medical care, Cost of | Cancer | Health care | Parameter estimation | Gemcitabine | Lung cancer | Clinical trials | Markov chains | Parameter sensitivity | Cancer therapies | Epidermal growth factor | Platinum | Parameter uncertainty | Protein-tyrosine kinase | Pharmaceutical sciences | Public health | Sensitivity analysis | Statistical analysis | Life expectancy | Small cell lung carcinoma | Epidermal growth factor receptors | Health risks | Non-small cell lung carcinoma | Patients | Hospitals | Pharmacy | Point mutation | Carboplatin | Mutation | Cost analysis
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 09/2018, Volume 13, Issue 1, pp. 168 - 6
Journal Article